Massih Ningarhari

6PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 20, 2026
Long-term survival and cure fraction in patients with advanced hepatocellular carcinoma under immunotherapy in randomized controlled trials and real-world data.

|Jul 05, 2025
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: The Blind Spot of HCC Management.

M Ningarhari, G Lassailly, S Dharancy

|Nov 30, 2023
Conventional cytotoxic chemotherapy for gastrointestinal cancer in patients with cirrhosis: A multicentre case-control study.

Massih Ningarhari, Marlène Bertez, Anne Ploquin

|Aug 26, 2022
Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety.

Isaure Roquette, Emilie Bogart, Thomas Lacornerie

|Jun 30, 2019
The role of telomeres and telomerase in cirrhosis and liver cancer.

Jean-Charles Nault, Massih Ningarhari, Sandra Rebouissou

Pageof 1